
Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy
Author(s) -
Fumiaki Kawara,
Tsuyoshi Fujita,
Yoshinori Morita,
Atsushi Uda,
Atsuhiro Masuda,
Masaya Saito,
Makoto Ooi,
Tatsuro Ishida,
Yasuyuki Kondo,
S Yoshida,
Tatsuya Okuno,
Yoshihiko Yano,
Masaru Yoshida,
Hiromu Kutsumi,
Takanobu Hayakumo,
K. Yamashita,
Tomoyuki Hirano,
Midori Hirai,
Takeshi Azuma
Publication year - 2017
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v23.i11.2060
Subject(s) - gerd , medicine , proton pump inhibitor , cyp2c19 , gastroenterology , reflux , rating scale , quality of life (healthcare) , reflux esophagitis , disease , psychology , developmental psychology , nursing , cytochrome p450 , metabolism
To elucidate the factors associated with residual gastroesophageal reflux disease (GERD) symptoms in patients receiving proton pump inhibitor (PPI) maintenance therapy in clinical practice.